Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective Study

NCT01502397 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT01502397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01502397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective Study
Lead sponsor
The University of Hong Kong
Phase
Observational
Overall status
Completed
Start date
December 31, 2011
Completion date
March 31, 2016
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exposure to hepatitis b virus